Moreover, studies reported that some chemicals, cytokines, and radiation therapies can activate the MHC signaling pathway and upregulate the expression of peptide/MHCs on tumor cell surfaces [177, 178], and combining immunotherapies with other therapies is the subject of active clinical investigations [179]. This evidence concerns the gene HLA-C and neoplasm.